One day we hope to be able to say — well, here’s a disease, and then click a button and out pops the design for a drug to ...

In an interview with Fortune, Isomorphic Labs president Colin Murdoch shared that four years after its founding, the company ...

Isomorphic Labs is preparing to test AI-designed drugs in humans, marking a new phase in drug development with artificial ...

Alphabet’s Isomorphic Labs, spun out of DeepMind, is preparing to start human trials of AI-designed drugs after raising $600 ...

A secretive, Google-backed lab is using artificial intelligence to invent new medicines for humanity's worst illnesses. But ...

Alphabet’s Isomorphic Labs is preparing to launch human trials of AI-designed drugs, its president, Colin Murdoch, told Fortune.Born from DeepMind’s AlphaFold breakthrough, the company is ...

Alphabet’s Isomorphic Labs is preparing to begin human trials of a drug designed using AI, based on protein modelling ...

The oncology drug created by Isomorphic Labs using Google DeepMind’s AlphaFold 3 tool could be pivotal for cancer treatment.

Google DeepMind's drug discovery company, Isomorphic Labs, is gearing up to launch the human trials of its AI-designed drugs.

Isomorphic Labs, the AI-powered drug company spun out of Google’s DeepMind, just announced that it’s “getting ready” to begin human clinical trials of drugs designed by AI.

Isomorphic Labs, a subsidiary of Alphabet Inc., is close to human trials for its AI-designed medicines. Other companies are ...

According to Colin Murdoch, president of Isomorphic Labs and DeepMind’s chief business officer, the company is close to achieving a major milestone by putting AI-designed drugs into human trials.